Johnson & Johnson - 48 Year Stock Price History | JNJ

Historical daily share price chart and data for Johnson & Johnson since 1970 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Johnson & Johnson as of October 17, 2018 is 139.46.
Johnson & Johnson Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2018 130.6666 137.3325 146.1211 119.4000 139.4600 1.19%
2017 126.3827 111.3861 140.9426 107.4630 137.8159 24.40%
2016 107.7696 93.9666 118.9545 89.5432 110.7803 15.32%
2015 91.8875 94.9164 98.4274 84.2322 96.0614 1.16%
2014 90.3412 80.4371 98.5488 76.5403 94.9618 17.34%
2013 74.6987 60.7557 84.5019 60.6699 80.9320 34.62%
2012 56.3714 54.4963 61.6558 52.0551 60.1210 10.83%
2011 51.6024 50.1393 55.1766 46.4376 54.2481 9.89%
2010 48.7009 49.8624 51.2940 44.7000 49.3651 -0.58%
2009 43.8430 45.2341 50.0782 35.0478 49.6542 11.28%
2008 47.7000 47.8080 53.4419 41.2663 44.6225 -7.77%
2007 45.8017 46.9642 49.6142 42.6856 48.3811 3.61%
2006 43.4829 42.5847 48.5971 39.2473 46.6954 12.44%
2005 44.2426 42.6180 47.2233 41.4861 41.5275 -3.36%
2004 37.5193 34.3305 43.2007 33.0397 42.9704 25.17%
2003 34.6389 36.1299 38.4640 32.2350 34.3305 -2.11%
2002 37.3734 37.8140 42.3206 27.1343 35.0721 -7.88%
2001 33.2494 32.4199 39.2763 26.5503 38.0717 13.97%
2000 28.2393 28.9587 33.4052 21.5950 33.4052 14.04%
1999 29.3805 25.6768 33.3281 23.9100 29.2916 12.46%
1998 23.1572 19.9418 27.6362 19.6169 26.0464 28.99%
1997 18.1618 15.0349 20.5181 15.0349 20.1932 34.31%
1996 14.5586 12.5435 16.2437 12.5435 15.0349 18.11%
1995 10.1651 7.9623 13.6229 7.8527 12.7296 59.14%
1994 6.6788 6.4521 8.1274 5.2728 7.9988 24.99%
1993 5.9153 6.8878 6.8878 5.0498 6.3993 -8.93%
1992 6.8059 7.6703 7.9525 5.9455 7.0270 -10.19%
1991 6.0772 4.7019 7.8924 4.4077 7.8240 62.34%
1990 4.1803 3.9389 4.8795 3.4206 4.8195 23.39%
1989 3.2588 2.6902 3.9060 2.6902 3.9060 42.63%
1988 2.5731 2.4520 2.8176 2.2085 2.7385 16.52%
1987 2.6859 2.0842 3.2662 2.0136 2.3503 15.80%
1986 1.9514 1.5705 2.2735 1.4455 2.0297 27.42%
1985 1.3307 1.0483 1.6574 1.0336 1.5929 49.85%
1984 0.9908 1.1622 1.2048 0.8167 1.0630 -8.54%
1983 1.2823 1.3746 1.4206 1.1158 1.1622 -15.66%
1982 1.1216 0.9927 1.4163 0.8862 1.3780 36.94%
1981 0.9141 0.8797 1.0296 0.7676 1.0063 14.55%
1980 0.6898 0.6574 0.8807 0.5736 0.8785 29.40%
1979 0.6091 0.6186 0.6853 0.5507 0.6789 10.50%
1978 0.6329 0.6112 0.7352 0.5402 0.6144 -1.77%
1977 0.5678 0.6238 0.6255 0.5028 0.6255 0.43%
1976 0.6852 0.7109 0.7593 0.5749 0.6228 -12.03%
1975 0.6987 0.6487 0.7775 0.5764 0.7080 12.01%
1974 0.7668 0.8666 0.9246 0.5857 0.6321 -27.70%
1973 0.9198 0.9920 1.0075 0.8104 0.8743 -13.22%
1972 0.9089 0.7518 1.0192 0.7296 1.0075 32.99%
1971 0.6532 0.4380 0.7605 0.4380 0.7576 73.72%
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $374.158B $76.450B
Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin care, oral care, wound care, and women's health fields, nutritional and over-the-counter pharmaceutical products. The company's Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, thrombosis, vaccines, and infectious diseases. Its Medical Devices and Diagnostics segment offers electrophysiology and circulatory disease management products; orthopaedic joint reconstruction, spinal care, neurological, and sports medicine products; surgical care, aesthetics, and women's health products. Johnson & Johnson is based in New Brunswick, New Jersey.
Stock Name Country Market Cap PE Ratio
Pfizer (PFE) United States $265.319B 15.53
Novartis AG (NVS) Switzerland $197.633B 16.95
Merck (MRK) United States $193.640B 17.10
AbbVie (ABBV) United States $139.722B 13.65
Eli Lilly (LLY) United States $121.994B 22.58
Sanofi (SNY) France $112.061B 14.18
Novo Nordisk (NVO) Denmark $106.293B 16.99
AstraZeneca (AZN) United Kingdom $99.517B 10.94
GlaxoSmithKline (GSK) United Kingdom $98.553B 13.16
Bristol-Myers Squibb (BMY) United States $96.274B 17.43